Pharma Journalist 8801 posts 0 comments

Novartis announced the United States Food & Drug Administration (FDA) placed a partial hold on clinical trials for intrathecal administration of AVXS-101. The announcement follows…
Read More...

Pandion Therapeutics and Astellas Pharma announced the signing of a License and Collaboration Agreement directed toward the research, development, and commercialization of locally…
Read More...

Biogen Inc. and Alkermes plc announced that the U.S. Food and Drug Administration (FDA) approved VUMERITY (diroximel fumarate), a novel oral fumarate with a distinct chemical structure,…
Read More...

Roche announced that the European Medicines Agency (EMA) has validated the company’s Marketing Authorisation Application (MAA) for satralizumab for the treatment of adult and adolescent…
Read More...

Pascal Biosciences Inc. and Y-Biologics announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia.…
Read More...

ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system…
Read More...

Cyclo Therapeutics, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease,…
Read More...

Boehringer Ingelheim presented promising preclinical data from its pan-KRAS program including the novel, oral inhibitor BI 1701963 at the AACR-NCI-EORTC International Conference on…
Read More...

Themis Bioscience and CEPI – the Coalition for Epidemic Preparedness Innovations – announced the first administration to healthy volunteers in a Phase 1 clinical trial with Themis’…
Read More...

The European Commission (EC) approved a new indication for Dupixent (dupilumab) in chronic rhinosinusitis with nasal polyposis (CRSwNP). Dupixent is indicated as an add-on therapy with…
Read More...